Literature DB >> 8958213

In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor.

Y Cao1, P Linden, D Shima, F Browne, J Folkman.   

Abstract

To investigate the in vivo angiogenic activity of placenta growth factor (PIGF) and its heterodimers with vascular endothelial growth factor (VEGF), the induction of neovascularization of these factors in the mouse cornea was studied. VEGF165 is sufficiently potent to stimulate new capillary growth from the limbal vessels. PIGF129/VEGF165 heterodimers also induce corneal neovascularization with a maximal vessel length similar to VEGF165, but with a marked decrease of vessel density. In contrast, PIGF129 has little or no effect in this in vivo angiogenesis assay. The expression of VEGF mRNA and protein is drastically up-regulated by hypoxia in choriocarcinoma cells, whereas expression of PIGF is not affected by the low concentration of oxygen. Up-regulation of VEGF production results in increased formation of PIGF/VEGF heterodimers in these tumor cells. Thus, hypoxia indirectly up-regulates expression levels of PIGF/VEGF heterodimers and modulates VEGF activity when these factors are co-expressed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958213      PMCID: PMC507708          DOI: 10.1172/JCI119069

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.

Authors:  Y Cao; H Chen; L Zhou; M K Chiang; B Anand-Apte; J A Weatherbee; Y Wang; F Fang; J G Flanagan; M L Tsang
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

Review 2.  Role of VEGF-flt receptor system in normal and tumor angiogenesis.

Authors:  M Shibuya
Journal:  Adv Cancer Res       Date:  1995       Impact factor: 6.242

3.  A model of angiogenesis in the mouse cornea.

Authors:  B M Kenyon; E E Voest; C C Chen; E Flynn; J Folkman; R J D'Amato
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-07       Impact factor: 4.799

4.  Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Authors:  A Sawano; T Takahashi; S Yamaguchi; M Aonuma; M Shibuya
Journal:  Cell Growth Differ       Date:  1996-02

5.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

6.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

7.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

8.  Vascular endothelial growth factor B, a novel growth factor for endothelial cells.

Authors:  B Olofsson; K Pajusola; A Kaipainen; G von Euler; V Joukov; O Saksela; A Orpana; R F Pettersson; K Alitalo; U Eriksson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

9.  A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

Authors:  V Joukov; K Pajusola; A Kaipainen; D Chilov; I Lahtinen; E Kukk; O Saksela; N Kalkkinen; K Alitalo
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

10.  gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice.

Authors:  Y Cao; C Chen; J A Weatherbee; M Tsang; J Folkman
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  44 in total

1.  Redox systems of the cell: possible links and implications.

Authors:  Kumuda C Das; Carl W White
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

Review 2.  Choriocarcinoma metastatic to the choroid.

Authors:  M C Kavanagh; S R Pakala; D A Hollander; J M O'Brien
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 3.  Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy.

Authors:  Mark W Dewhirst; Yiting Cao; Chuan Yuan Li; Benjamin Moeller
Journal:  Radiother Oncol       Date:  2007-06-08       Impact factor: 6.280

4.  Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

Authors:  Marcella Marcellini; Naomi De Luca; Teresa Riccioni; Alessandro Ciucci; Angela Orecchia; Pedro Miguel Lacal; Federica Ruffini; Maurizio Pesce; Francesca Cianfarani; Giovanna Zambruno; Augusto Orlandi; Cristina Maria Failla
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 5.  Adhesion molecules in rheumatoid arthritis.

Authors:  N Oppenheimer-Marks; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  1998

6.  Gene Expression Profiling Identifies Cell Proliferation and Inflammation as the Predominant Pathways Regulated by Aryl Hydrocarbon Receptor in Primary Human Fetal Lung Cells Exposed to Hyperoxia.

Authors:  Binoy Shivanna; Suman Maity; Shaojie Zhang; Ananddeep Patel; Weiwu Jiang; Lihua Wang; Stephen E Welty; John Belmont; Cristian Coarfa; Bhagavatula Moorthy
Journal:  Toxicol Sci       Date:  2016-04-21       Impact factor: 4.849

7.  Vascular endothelial growth factor C induces angiogenesis in vivo.

Authors:  Y Cao; P Linden; J Farnebo; R Cao; A Eriksson; V Kumar; J H Qi; L Claesson-Welsh; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.

Authors:  Renhai Cao; Yuan Xue; Eva-Maria Hedlund; Zhaodong Zhong; Katerina Tritsaris; Barbara Tondelli; Franco Lucchini; Zhenping Zhu; Steen Dissing; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.

Authors:  B Witzenbichler; T Asahara; T Murohara; M Silver; I Spyridopoulos; M Magner; N Principe; M Kearney; J S Hu; J M Isner
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 10.  PlGF: a multitasking cytokine with disease-restricted activity.

Authors:  Mieke Dewerchin; Peter Carmeliet
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.